Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

355
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
355
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

394
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
394
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.7K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K
Cancer Vaccines01:30

Cancer Vaccines

852
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
852
Vaccinations01:51

Vaccinations

50.5K
Overview
50.5K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

579
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
579

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Lab creates new kind of synthetic cell.

Science (New York, N.Y.)·2026
Same author

Big Ebola outbreak puts research spotlight on little-known virus.

Science (New York, N.Y.)·2026
Same author

Antiviral pill gets first test for Ebola prevention.

Science (New York, N.Y.)·2026
Same author

Ebola outbreak puts nimble treatment trial designs to the test.

Science (New York, N.Y.)·2026
Same author

Scientists play catch-up to startling Ebola outbreak.

Science (New York, N.Y.)·2026
Same author

Cruise ship outbreak spotlights a little-studied hantavirus.

Science (New York, N.Y.)·2026

関連する実験動画

Updated: Dec 7, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K

"バットマン"がCOVID-19に打ち勝つ

Kai Kupferschmidt

    Science (New York, N.Y.)
    |October 2, 2020
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
    05:49

    Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

    Published on: November 21, 2023

    2.2K
    Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
    07:13

    Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

    Published on: April 9, 2021

    4.5K

    関連する実験動画

    Last Updated: Dec 7, 2025

    Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
    08:41

    Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

    Published on: November 5, 2021

    3.1K
    Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
    05:49

    Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

    Published on: November 21, 2023

    2.2K
    Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
    07:13

    Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

    Published on: April 9, 2021

    4.5K